Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1 (GLP-1) crafted to enhance receptor activity over an extended period. In laboratory and preclinical studies, semaglutide is investigated for its engagement with the GLP-1 receptor (GLP-1R), its receptor-binding properties, subsequent intracellular signaling, and the relationships between its structure and activity.

For Research Use Only. Not intended for human or veterinary use. Not for diagnostic, therapeutic, or clinical use.